Keywords: Validus Pharmaceuticals, Novartis, Established product lines, USA

Validus Pharma gets rights to six Novartis drugs in USA

Article | 19 November 2012

USA-based Validus Pharmaceuticals (NYSE: VR) together with Wood Creek Capital Management, have acquired USs rights to six well-known product lines, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Validus Pharma

Go to company listing